Respiratory Medicine
Volume 104, Issue 8 , Pages 1101-1109 , August 2010

Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma

  • P. Chanez

      Affiliations

    • Université de la Méditerranée, Marseille, France
    • Corresponding Author InformationCorresponding author.
    • ,
  • R. Stallaert

      Affiliations

    • Westfries Gasthuis, Fr. Maelsonstraat 3, 1624 NP HOORN (NH), The Netherlands
    • ,
  • E. Reznikova

      Affiliations

    • Sadovnikova iela 20, Riga, Latvia
    • ,
  • P. Bloemen

      Affiliations

    • GlaxoSmithKline, Zeist, The Netherlands
    • ,
  • L. Adamek

      Affiliations

    • GlaxoSmithKline, EU Respiratory Centre of Excellence, Marly le Roi, France
    • ,
  • G. Joos

      Affiliations

    • Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium

Received 2 November 2009 ,Accepted 5 April 2010.

References 

  1. Global Strategy for Asthma Management and Prevention . Global Initiative for asthma (GINA) (Revised 2009). Available from: http://www.ginasthma.org
  2. Warke TJ, Fitch PS, Brown V, Taylor R, Lyons JDM, Ennis M, et al. Outgrown asthma does not mean no airways inflammation. Eur Respir J. 2002;19:284–287
  3. Toorn van den LM, Overbeek- SE, De Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Med. 2001;164:2107–2113
  4. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax. 2002;57:309–316
  5. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789–815
  6. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma – from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–1745
  7. National Asthma Education and Prevention Program . Expert Report Panel 3. Guidelines for the diagnosis and management of asthma. National Institutes of Health; 2007;NIH publication no. 084846
  8. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31:320–325
  9. Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev. 2009;18:105–112
  10. Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandström T, Lindberg A, et al. Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. J Allergy Clin Immunol. 2003;112:72–78
  11. Lundbäck B, Ronmark E, Lindberg A, Jonsson AC, Larson LG, Petavy F, et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med. 2006;100:2–10
  12. Orsida BE, Ward C, Li X, Bish R, Wilson JW, Thien F, et al. Effect of a long-acting beta(2)-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med. 2001;164:117–121
  13. Morrison KJ, Gao Y, Vanhoutte PM. Beta-adrenoceptors and the epithelial layer in airways. Life Sci. 1993;52:2123–2130
  14. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, et al. Can guideline-asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med. 2004;170:836–844
  15. Bateman ED, Clark TJH, Frith L, Bousquet J, Busse WW, Pedersen SE, et al. Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the Goal study. J Asthma. 2007;44:667–673
  16. Woolcock AJ. What are the important questions in the treatment of asthma?. Clin Exp Allergy Rev. 2001;1(2):62–64
  17. American Thoracic Society . Guidelines for methacholine and exercise challenge testing – 1999. Am J Respir Crit Care Med. 2000;161:309–329
  18. Quanjer Ph. Standardised lung function testing. Bull Eur Physiopathol Respir. 1983;19(Suppl. 5):1–95
  19. Sont JK, Willems LNA, Bel EH, van Krieken JHJM, Vandenbroucke JP, Sterk PJ, et al. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999;159:1043–1051
  20. Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, et al. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?. Respir Med. 2008;102:665–673
  21. Nuijsink M, Hop WCJ, Sterk PJ, Duiverman EJ, de Jongste JC, on behalf of the Children Asthma Therapy Optimal (CATO) Study Group . Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J. 2007;30:457–466
  22. Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008;32:545–554
  23. Lundbäck B, Rönmark E, Lindberg A, Jonsson A-C, Larsson L-G, James M. Asthma control over three years in a real life study. Respir Med. 2008;103:348–355
  24. Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J. 2000;16:226–235
  25. Brutsche MH, Downs SH, Schinler C, Gerbase MW, Schwartz J, Frey M, et al. for the SAPALDIA team Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax. 2006;61:671–677
  26. Limb SL, Brown KC, Wood RA, Wise RA, Eggleston E, Tonascia J, et al. Irreversible lung function deficits in young adults with a history of childhood asthma. J Allergy Clin Immunol. 2005;116:1213–1219
  27. Fitzgerald J, Boulet LP, Follows R, The CONCEPT Trial . A 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. Clin Ther. 2005;27(4):393–406

PII: S0954-6111(10)00154-X

doi: 10.1016/j.rmed.2010.04.001

Respiratory Medicine
Volume 104, Issue 8 , Pages 1101-1109 , August 2010

Article Tools

* Image Usage & Resolution